OK Biotech Co (4155.TW) Stock Price

OK Biotech Co Price

TWSE·CLOSED
16.65
​
Market closed

Over the last 18 years OK Biotech Co grew revenue by 30.1% annually, reaching 1.56 B TWD. Earnings per share have grown at 3.8% per year over the last 17 years. For OK Biotech Co, the net margin of 5.3% is up versus 2.5% a few years ago. At today's price the dividend yield works out to roughly 2.01%. The payout ratio is around 64% of earnings. The dividend has grown at 1.5% per year over the past 14 years.

OK Biotech Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OK Biotech Co business model & stock analysis

OK Biotech Co. Ltd. engages in the manufacture, wholesale, trade, and retail of medical equipment and related homecare medical products. The company is headquartered in Hsinchu, Hsinchu. The company went IPO on 2010-12-30. The firm primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The firm distributes its products principally in Taiwan, other Asian markets and the United States.

Frequently asked questions about OK Biotech Co

7 analysts currently rate the OK Biotech Co stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect OK Biotech Co to generate revenue of 1.27 B TWD and earnings per share of 1.35 TWD.

Converted at the current exchange rate, the OK Biotech Co share trades at 0.45 EUR (16.65 TWD).

The OK Biotech Co share (4155.TW) is listed on 1 stock exchanges, including: TWSE (Taiwan) (4155.TW).

The expected revenue of OK Biotech Co is 1.27 B TWD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of OK Biotech Co is 211.53 M TWD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of OK Biotech Co is currently 12.37. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the OK Biotech Co stock.

The price-to-sales ratio (P/S) of OK Biotech Co is currently 2.06. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the OK Biotech Co stock.

The Eulerpool Quality Score for OK Biotech Co is 2/10.

The ISIN of OK Biotech Co is TW0004155007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of OK Biotech Co is 4155.TW. The ticker symbol is used to trade OK Biotech Co shares on the stock exchange.

Fair ValueTerminal
15.48 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Dec 30, 2010
ISIN
TW0004155007
Cusip
Y6472C102
Market capitalization
2.41 B TWDMid Cap
52-Week Range
PEG
5.37
P/E ratio
P/Ee 2026
11.40
P/Ee 2027
11.54
P/Ee 2028
10.94
P/Ee 2029
7.26
P/Ee 2030
12.10
P/S
P/Se
2.06
EV/EBIT
29.02
P/B Ratio
0.96
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
2.32 %
Dividend
Dividend yield
2.01 %
Est. Dividend Yield
2.01 %
Payout Ratio
63.79 %
Dividend growth Ø5Y
-24.61 %
Dividend payments per year
1
Dividend paid since
15 years
Dividend not reduced since
1 year
Dividend increased since
0 years
Dividend withholding tax
21.00 %
Last updated Nov 6, 2026, 3:39 AM

OK Biotech Co Peer Group

OK Biotech Co Ticker

TWSE · 4155.TW

OK Biotech Co FIGI

4155:TT (Taiwan Stock Exchange) · BBG001CMX5Z9

All fundamentals and in-depth analysis of OK Biotech Co

Our stock analysis for OK Biotech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OK Biotech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.